p tak 1 Search Results


anti p tak1  (Novus Biologicals)
94
Novus Biologicals anti p tak1
Anti P Tak1, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti p tak1/product/Novus Biologicals
Average 94 stars, based on 1 article reviews
anti p tak1 - by Bioz Stars, 2026-02
94/100 stars
  Buy from Supplier
tgfβ-activated kinase 1 (tak1  (Beyotime)
90
Beyotime tgfβ-activated kinase 1 (tak1
Tgfβ Activated Kinase 1 (Tak1, supplied by Beyotime, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/tgfβ-activated kinase 1 (tak1/product/Beyotime
Average 90 stars, based on 1 article reviews
tgfβ-activated kinase 1 (tak1 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
p-tak1 antibody  (ImmunoWay Biotechnology Company)
90
ImmunoWay Biotechnology Company p-tak1 antibody
NLRC5 regulates microglial activation via promoting phosphorylation of IKKα/β. ( A ) Representative Western blot image of p-IKKα/β, IKKα/β, p-IκB and IκB in BV2-shCtrl and BV2-sh Nlrc5 cells treated with LPS (10 ng/mL) for different times. Bars represent the relative fold change of p-IKKα/β to IKKα/β ( B ) and p-IκB to IκB ( C ) (n = 5 for each group). ( D ) Representative Western blot image of <t>p-TAK1</t> and TAK1 in BV2-shCtrl and BV2-sh Nlrc5 cells treated with LPS. ( E ) Bars represent the relative fold change of p-TAK1 to TAK1 (n = 5 for each group). ( F ) Anti-NLRC5 was used to precipitate IKKα/β from BV2-shCtrl and BV2-sh Nlrc5 cell extracts. P-IKKα/β and IKKα/β were subsequently determined by Western blot analysis. ( G ) Representative Western blot image of p-IKKα/β, IKKα/β, p-IκB and IκB in RAW264.7-shCtrl and RAW264.7-sh Nlrc5 cells treated with LPS. Bars represent the relative fold change of p-IKKα/β to IKKα/β. ( H ) and p-IκB to IκB ( I ) (n = 5 for each group). All data were presented as mean ± SEM (( B ), LPS: F (3, 32) = 11.51, p < 0.001; NLRC5: F (1, 32) = 15.95, p < 0.001; Interaction: F (3, 32) = 3.201, p < 0.05; ( C ), LPS: F (3, 32) = 8.843, p < 0.001; NLRC5: F (1, 32) = 9.209, p < 0.01; Interaction: F (3, 32) = 4.286, p < 0.05; ( E ), LPS: F (3, 32) = 5.683, p < 0.01; NLRC5: F (1, 32) = 0.3470, p = 0.5600; Interaction: F (3, 32) = 0.1702, p = 0.9157; ( H ), LPS: (3, 32) = 78.14, p < 0.001; NLRC5: F (1, 32) = 8.092, p < 0.01; Interaction: F (3, 32) = 6.471, p < 0.01; ( I) , LPS: (3, 32) = 47.36, p < 0.001; NLRC5: F (1, 32) = 6.760, p < 0.05; Interaction: F (3, 32) = 3.143, p < 0.05). A two-way ANOVA was used to determine the statistical significance of the two groups. * p ≤ 0.05, ** p ≤ 0.01, and *** p ≤ 0.001. ns: no significant difference. p-IKKα/β: phosphorylated IKKα/β; p-IκB: phosphorylated IκB; p-TAK1: phosphorylated TAK1.
P Tak1 Antibody, supplied by ImmunoWay Biotechnology Company, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/p-tak1 antibody/product/ImmunoWay Biotechnology Company
Average 90 stars, based on 1 article reviews
p-tak1 antibody - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
rabbit polyclonal anti-phospho-tak1 (thr184/thr187)  (Affinity Biosciences)
90
Affinity Biosciences rabbit polyclonal anti-phospho-tak1 (thr184/thr187)

Rabbit Polyclonal Anti Phospho Tak1 (Thr184/Thr187), supplied by Affinity Biosciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit polyclonal anti-phospho-tak1 (thr184/thr187)/product/Affinity Biosciences
Average 90 stars, based on 1 article reviews
rabbit polyclonal anti-phospho-tak1 (thr184/thr187) - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
antibodies for tak1, ikb-α, p-ikb-α, p65, and p-p65  (Wuhan Sanying Biotechnology)
90
Wuhan Sanying Biotechnology antibodies for tak1, ikb-α, p-ikb-α, p65, and p-p65

Antibodies For Tak1, Ikb α, P Ikb α, P65, And P P65, supplied by Wuhan Sanying Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/antibodies for tak1, ikb-α, p-ikb-α, p65, and p-p65/product/Wuhan Sanying Biotechnology
Average 90 stars, based on 1 article reviews
antibodies for tak1, ikb-α, p-ikb-α, p65, and p-p65 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
primary antibodies against tak1 l  (GeneTex)
90
GeneTex primary antibodies against tak1 l

Primary Antibodies Against Tak1 L, supplied by GeneTex, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/primary antibodies against tak1 l/product/GeneTex
Average 90 stars, based on 1 article reviews
primary antibodies against tak1 l - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

Image Search Results


NLRC5 regulates microglial activation via promoting phosphorylation of IKKα/β. ( A ) Representative Western blot image of p-IKKα/β, IKKα/β, p-IκB and IκB in BV2-shCtrl and BV2-sh Nlrc5 cells treated with LPS (10 ng/mL) for different times. Bars represent the relative fold change of p-IKKα/β to IKKα/β ( B ) and p-IκB to IκB ( C ) (n = 5 for each group). ( D ) Representative Western blot image of p-TAK1 and TAK1 in BV2-shCtrl and BV2-sh Nlrc5 cells treated with LPS. ( E ) Bars represent the relative fold change of p-TAK1 to TAK1 (n = 5 for each group). ( F ) Anti-NLRC5 was used to precipitate IKKα/β from BV2-shCtrl and BV2-sh Nlrc5 cell extracts. P-IKKα/β and IKKα/β were subsequently determined by Western blot analysis. ( G ) Representative Western blot image of p-IKKα/β, IKKα/β, p-IκB and IκB in RAW264.7-shCtrl and RAW264.7-sh Nlrc5 cells treated with LPS. Bars represent the relative fold change of p-IKKα/β to IKKα/β. ( H ) and p-IκB to IκB ( I ) (n = 5 for each group). All data were presented as mean ± SEM (( B ), LPS: F (3, 32) = 11.51, p < 0.001; NLRC5: F (1, 32) = 15.95, p < 0.001; Interaction: F (3, 32) = 3.201, p < 0.05; ( C ), LPS: F (3, 32) = 8.843, p < 0.001; NLRC5: F (1, 32) = 9.209, p < 0.01; Interaction: F (3, 32) = 4.286, p < 0.05; ( E ), LPS: F (3, 32) = 5.683, p < 0.01; NLRC5: F (1, 32) = 0.3470, p = 0.5600; Interaction: F (3, 32) = 0.1702, p = 0.9157; ( H ), LPS: (3, 32) = 78.14, p < 0.001; NLRC5: F (1, 32) = 8.092, p < 0.01; Interaction: F (3, 32) = 6.471, p < 0.01; ( I) , LPS: (3, 32) = 47.36, p < 0.001; NLRC5: F (1, 32) = 6.760, p < 0.05; Interaction: F (3, 32) = 3.143, p < 0.05). A two-way ANOVA was used to determine the statistical significance of the two groups. * p ≤ 0.05, ** p ≤ 0.01, and *** p ≤ 0.001. ns: no significant difference. p-IKKα/β: phosphorylated IKKα/β; p-IκB: phosphorylated IκB; p-TAK1: phosphorylated TAK1.

Journal: International Journal of Molecular Sciences

Article Title: NLRC5 Deficiency Reduces LPS-Induced Microglial Activation via Inhibition of NF-κB Signaling and Ameliorates Mice’s Depressive-like Behavior

doi: 10.3390/ijms241713265

Figure Lengend Snippet: NLRC5 regulates microglial activation via promoting phosphorylation of IKKα/β. ( A ) Representative Western blot image of p-IKKα/β, IKKα/β, p-IκB and IκB in BV2-shCtrl and BV2-sh Nlrc5 cells treated with LPS (10 ng/mL) for different times. Bars represent the relative fold change of p-IKKα/β to IKKα/β ( B ) and p-IκB to IκB ( C ) (n = 5 for each group). ( D ) Representative Western blot image of p-TAK1 and TAK1 in BV2-shCtrl and BV2-sh Nlrc5 cells treated with LPS. ( E ) Bars represent the relative fold change of p-TAK1 to TAK1 (n = 5 for each group). ( F ) Anti-NLRC5 was used to precipitate IKKα/β from BV2-shCtrl and BV2-sh Nlrc5 cell extracts. P-IKKα/β and IKKα/β were subsequently determined by Western blot analysis. ( G ) Representative Western blot image of p-IKKα/β, IKKα/β, p-IκB and IκB in RAW264.7-shCtrl and RAW264.7-sh Nlrc5 cells treated with LPS. Bars represent the relative fold change of p-IKKα/β to IKKα/β. ( H ) and p-IκB to IκB ( I ) (n = 5 for each group). All data were presented as mean ± SEM (( B ), LPS: F (3, 32) = 11.51, p < 0.001; NLRC5: F (1, 32) = 15.95, p < 0.001; Interaction: F (3, 32) = 3.201, p < 0.05; ( C ), LPS: F (3, 32) = 8.843, p < 0.001; NLRC5: F (1, 32) = 9.209, p < 0.01; Interaction: F (3, 32) = 4.286, p < 0.05; ( E ), LPS: F (3, 32) = 5.683, p < 0.01; NLRC5: F (1, 32) = 0.3470, p = 0.5600; Interaction: F (3, 32) = 0.1702, p = 0.9157; ( H ), LPS: (3, 32) = 78.14, p < 0.001; NLRC5: F (1, 32) = 8.092, p < 0.01; Interaction: F (3, 32) = 6.471, p < 0.01; ( I) , LPS: (3, 32) = 47.36, p < 0.001; NLRC5: F (1, 32) = 6.760, p < 0.05; Interaction: F (3, 32) = 3.143, p < 0.05). A two-way ANOVA was used to determine the statistical significance of the two groups. * p ≤ 0.05, ** p ≤ 0.01, and *** p ≤ 0.001. ns: no significant difference. p-IKKα/β: phosphorylated IKKα/β; p-IκB: phosphorylated IκB; p-TAK1: phosphorylated TAK1.

Article Snippet: The corresponding antibodies to the protein of interest for immunoblotting included p-IKKα/β (Cell Signaling Technology, Danvers, MA, USA, 2697, 1:1000 dilution), p-I k B (Cell Signaling Technology, 9246, 1:1000 dilution), IKKα/β (Abcam, Cambridge, MA, USA, ab178870, 1:1000 dilution), I k B (Cell Signaling Technology, 9242, 1:1000 dilution), p65 (BD Bioscience, San Jose, CA, USA, 610868, 1:1000 dilution), NLRC5 (Abcam, ab105411, 1:500 dilution), p-TAK1 (ImmunoWay, Plano, TX, USA, YP1522, 1:500 dilution), TAK1 (ImmunoWay, YT4536, 1:1000 dilution), cleaved-Caspase-1 p20 (Santa Cruz Biotechnology, Santa Cruz, CA, USA, sc1218, 1:1000 dilution), β-actin (Sigma-Aldrich, A5441, 1:5000 dilution), and Histone-3 (Cell Signaling Technology, 4499, 1:2000 dilution).

Techniques: Activation Assay, Phospho-proteomics, Western Blot

Journal: iScience

Article Title: Tripartite motif 38 attenuates cardiac fibrosis after myocardial infarction by suppressing TAK1 activation via TAB2/3 degradation

doi: 10.1016/j.isci.2022.104780

Figure Lengend Snippet:

Article Snippet: Rabbit polyclonal anti-Phospho-TAK1 (Thr184/Thr187) , Affinity Biosciences , Cat#AF4379; RRID: AB_2844444.

Techniques: Recombinant, Protease Inhibitor, Modification, Bicinchoninic Acid Protein Assay, Staining, Software